Overview of Maraviroc
Maraviroc, with the NDC code 31722-0579, is a medication manufactured by Camber Pharmaceuticals, Inc. It is used in the treatment of HIV-1 infection, often in combination with other antiretroviral drugs. Here’s a detailed analysis of the market and price projections for this drug.
Market Context
Pharmaceutical Market Trends
The pharmaceutical market, particularly for antiretroviral drugs, is subject to various trends and factors that influence pricing and demand. According to Vizient, Inc., the overall drug price inflation rate for pharmaceuticals is projected to be around 3.8% in 2025, driven significantly by specialty pharmaceuticals, including those for HIV treatment[3].
Specialty Pharmaceuticals
Specialty pharmaceuticals, which include drugs like Maraviroc, are a significant segment of the market. These drugs treat complex or chronic conditions and often come with higher price tags. The increasing utilization of such drugs, along with the expansion of gene therapies, is expected to drive up provider spend[3].
Price Projections
General Trends
The price of Maraviroc, like other pharmaceuticals, is influenced by several factors including production costs, market demand, regulatory changes, and competition from generic or biosimilar alternatives.
- Inflation Rates: The projected drug price inflation rate of 3.8% suggests that prices for Maraviroc could increase accordingly. However, this is a general trend and specific prices can vary based on other factors[3].
Specific Price Movements
While the sources do not provide specific price increases for Maraviroc (NDC: 31722-0579), the median price increase for generic drugs has been significant in recent years. For instance, the median price increase for generic drugs was reported to be 19.9% in 2022[5].
Regulatory and Transparency Factors
Regulatory measures aimed at increasing transparency and controlling drug prices can impact the pricing of Maraviroc. For example, Oregon’s Drug Price Transparency Program requires manufacturers to report price increases and new high-cost drugs, which can lead to more scrutiny and potential regulatory actions to control price hikes[5].
Supply Chain and Market Dynamics
Supply Chain Influences
The price of Maraviroc is also influenced by the interactions and financial negotiations within the pharmaceutical supply chain. This includes the roles of manufacturers, pharmacy benefit managers (PBMs), and health insurers. Changes in these dynamics, such as shifts in formulary strategies or rebate policies, can affect the final cost of the drug to consumers[5].
Biosimilars and Generics
The introduction of biosimilars or generic versions of Maraviroc could potentially reduce its price. However, as seen with other drugs like Humira, biosimilars may not immediately gain significant market share until they are mandated at the payer level[3].
Key Takeaways
- Market Trends: The pharmaceutical market is experiencing a projected inflation rate of 3.8%, driven by specialty pharmaceuticals.
- Price Projections: While specific price increases for Maraviroc are not provided, the general trend suggests a potential increase in line with the overall market inflation rate.
- Regulatory Impact: Transparency programs and regulatory measures can influence pricing and may lead to more controlled price increases.
- Supply Chain Dynamics: Changes in the supply chain, including formulary strategies and rebate policies, can affect the final cost of the drug.
FAQs
What is Maraviroc used for?
Maraviroc is used in the treatment of HIV-1 infection, often in combination with other antiretroviral drugs.
Who manufactures Maraviroc with the NDC code 31722-0579?
Maraviroc with the NDC code 31722-0579 is manufactured by Camber Pharmaceuticals, Inc.
What is the projected drug price inflation rate for 2025?
The projected drug price inflation rate for 2025 is around 3.8%, driven significantly by specialty pharmaceuticals[3].
How do regulatory measures impact drug prices?
Regulatory measures such as transparency programs and affordability boards can lead to more scrutiny and potential actions to control price hikes, influencing the final cost of drugs to consumers[5].
Can biosimilars affect the price of Maraviroc?
Yes, the introduction of biosimilars could potentially reduce the price of Maraviroc, although their market share may take time to grow significantly[3].
Sources
- Findacode: Camber Pharmaceuticals, Inc. - List of Drugs - NDC Labeler[1].
- Vizient Inc.: Vizient projects drug price inflation at 3.81%[2].
- Vizient Inc.: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals[3].
- Findacode: Camber Pharmaceuticals - List of Drugs - NDC Labeler/Manufacturer[4].
- Oregon Department of Consumer and Business Services: Prescription Drug Price Transparency Results and Recommendations[5].
